Quantcast

Latest autoimmune diseases Stories

2014-06-25 23:13:19

Over 300 participants walked a course of two miles led by author Andrew Louis Botieri to help raise funds that will go towards providing essential support resources and educational forums for patients and families affected by scleroderma. Boston, MA (PRWEB) June 25, 2014 Andrew Louis Botieri, whose astonishing recovery from scleroderma is captured in his life-changing autobiography “A Celebration of Life: A Story of Hope, a Miracle, and the Power of Attitude”, led the Walk, Talk and...

2014-06-25 16:26:20

CHICAGO, June 25, 2014 /PRNewswire-USNewswire/ -- Bruce Richardson, M.D., Ph.D., of the University of Michigan, was honored Wednesday as the second recipient of the Lupus Insight Prize, the award for use in innovative research on lupus, an unpredictable and sometimes fatal autoimmune disease that affects an estimated 1.5 million Americans. Dr. Richardson received the Prize during a formal ceremony at FOCIS 2014, the 14(th) Annual Meeting of the Federation of Clinical Immunology...

2014-06-25 12:30:48

MENLO PARK, Calif., June 25, 2014 /PRNewswire/ -- Virobay, Inc., a clinical stage pharmaceutical company with a broad platform of cathepsin protease inhibitors being developed for the treatment of neuropathic pain, autoimmune diseases and fibrosis, today announced the appointment of James Welch as Chief Financial Officer, effective as of June 20, 2014. Mr. Welch has more than 20 years of experience in financial and operational management at life science and high technology firms....

2014-06-25 08:31:40

GURNEE, Ill., June 25, 2014 /PRNewswire/ -- Quest Products announces the national launch of ProVent® Eczema and Psoriasis Spray®, a spray formulated to help minimize the appearance of skin conditions often associated with Eczema and Psoriasis. The patented formula provides non-steroidal, natural relief and contains no parabens, no artificial dyes, and no artificial fragrances. ProVent® Eczema and Psoriasis Spray® contains extracts from twenty-five different herbs, and is based...

2014-06-25 08:26:32

Dominique's Diabetes Dream Team gives insider tips to people with type 2 diabetes through a national campaign and his "Diabetes Coaches' Clipboard" PLAINSBORO, N.J., June 25, 2014 /PRNewswire/ -- Novo Nordisk is teaming up with NBA great and Hall of Famer Dominique Wilkins to launch Dominique's Diabetes Dream Team, a national initiative to help adults with type 2 diabetes customize a full-court approach to managing the everyday challenges of the disease....

2014-06-24 08:32:22

Interlaken Leadership Awards Program Supports Original Research in the Field of Neuroimmunology KING OF PRUSSIA, Pa., June 24, 2014 /PRNewswire/ -- CSL Behring announced today that Bart C. Jacobs, M.D., Ph.D., Erasmus University Medical Center, Rotterdam, Netherlands, is the recipient of the 2014 Interlaken Leadership Awards for original research in the field of neuroimmunology. Established in 2010, this annual global awards program provides monetary grants and/or product supply for...

2014-06-20 23:05:58

The aim of this webinar is to enable the end-user to select the best model and study design for their research utilising in vivo inflammatory bowel disease (IBD) models. The live broadcast will be taking place on Thursday, July 10, 2014 at 11 a.m. EDT / 4 p.m. BST (UK GMT +1). Toronto, Canada (PRWEB) June 20, 2014 This webinar is aimed at improving the end-users’ understanding of pre-clinical in vivo inflammatory bowel disease (IBD) models, addressing issues associated with the various...

Man With Hair-Loss Disease Gets New Growth Using Arthritis Drug
2014-06-19 15:21:48

Gerard LeBlond for redorbit.com - Your Universe Online Doctors at Yale University administered treatment for a non curable disease (alopecia universalis) in a 25-year-old man that left him without any hair. After the treatment, the man grew a full head of hair, eyebrows, eyelashes, armpit, facial and other hair on various parts of his body. His disease had not been previously treated and this was the first reported case with successful results. “The results are exactly what we...

2014-06-19 09:35:10

The JAMA Network Journals In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer over a median follow-up of 3.7 years, although an increased risk of malignancy in the long term, or with increasing number of doses, cannot be excluded, according to a study in the June 18 issue of JAMA. Tumor necrosis factor α (TNF-α)...

2014-06-19 04:21:28

DIEPENBEEK, Belgium, June 19, 2014 /PRNewswire/ -- Initiates Preclinical Development of Peptide Therapy Apitope, the drug discovery and development company focused on disease-modifying treatments for patients with autoimmune and allergic diseases, announced today that it has started preclinical development of its novel peptide therapy ATX-GD-459 for the treatment of Graves' disease. Apitope, through its innovative discovery platform, has selected three peptides...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related